My Quote Request
6505-00-149-3503
20 Products
NDC00074-1746-50
BUPIVACAINE AND EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505001493503
NSN
6505-00-149-3503
NDC00074-1746-50
BUPIVACAINE AND EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505001493503
NSN
6505-00-149-3503
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.0005 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 0.250 PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE AND EPINEPHRINE INJECTION USP 50ML AMPUL 5 PER BX
III SUPPLEMENTARY FEATURES: SINGLE-DOSE AMPUL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: SUITABLE FOR CAUDAL,EPIDURAL,OR PERIPHERAL NERVE BLOCK
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00093-0262-92
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505001490164
NSN
6505-00-149-0164
NDC00093-0262-92
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505001490164
NSN
6505-00-149-0164
MFG
LEMMON CO
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 60GM TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: GREASELESS; NON-STAINING; ANHYDROUS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC49158-0212-24
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505001490164
NSN
6505-00-149-0164
NDC49158-0212-24
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505001490164
NSN
6505-00-149-0164
MFG
THAMES PHARMACAL CO INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 60GM TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: GREASELESS; NON-STAINING; ANHYDROUS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC51672-1253-03
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505001490164
NSN
6505-00-149-0164
NDC51672-1253-03
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505001490164
NSN
6505-00-149-0164
MFG
TARO PHARMACEUTICALS USA INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 60GM TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: GREASELESS; NON-STAINING; ANHYDROUS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
MYLANTA-II
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505001490247
NSN
6505-00-149-0247
MYLANTA-II
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505001490247
NSN
6505-00-149-0247
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 400.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 400.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 30.000 TO 40.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 OUNCES OR 148.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 48
Related Searches:
NDC00038-0652-05
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505001490247
NSN
6505-00-149-0247
NDC00038-0652-05
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505001490247
NSN
6505-00-149-0247
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 400.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 400.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 30.000 TO 40.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 OUNCES OR 148.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 48
Related Searches:
C0NRAYS0LUTI0N
IOTHALAMATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505001490249
NSN
6505-00-149-0249
C0NRAYS0LUTI0N
IOTHALAMATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505001490249
NSN
6505-00-149-0249
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
CHLORTRIMETON
CHLORPHENIRAMINE MALEATE SYRUP,USP
NSN, MFG P/N
6505001490333
NSN
6505-00-149-0333
CHLORTRIMETON
CHLORPHENIRAMINE MALEATE SYRUP,USP
NSN, MFG P/N
6505001490333
NSN
6505-00-149-0333
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE SYRUP USP 0.4MG 4OZ BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-0835-03
CHLORPHENIRAMINE MALEATE SYRUP,USP
NSN, MFG P/N
6505001490333
NSN
6505-00-149-0333
NDC00085-0835-03
CHLORPHENIRAMINE MALEATE SYRUP,USP
NSN, MFG P/N
6505001490333
NSN
6505-00-149-0333
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE SYRUP USP 0.4MG 4OZ BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MINOCIN
MINOCYCLINE HYDROCHLORIDE,USP
NSN, MFG P/N
6505001490574
NSN
6505-00-149-0574
MINOCIN
MINOCYCLINE HYDROCHLORIDE,USP
NSN, MFG P/N
6505001490574
NSN
6505-00-149-0574
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MINOCYCLINE HYDROCHLORIDE STERILE USP 100MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00205-5305-94
MINOCYCLINE HYDROCHLORIDE,USP
NSN, MFG P/N
6505001490574
NSN
6505-00-149-0574
NDC00205-5305-94
MINOCYCLINE HYDROCHLORIDE,USP
NSN, MFG P/N
6505001490574
NSN
6505-00-149-0574
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MINOCYCLINE HYDROCHLORIDE STERILE USP 100MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00024-1535-48
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505001490746
NSN
6505-00-149-0746
NDC00024-1535-48
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505001490746
NSN
6505-00-149-0746
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEXACHLOROPHENE CLEANSING EMULSION USP 5 FL OZ (148ML) 48S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 FLUID OUNCES OR 148.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SUBSTITUTE FOR PREFERRED NSN 6505-01-077-4952
TOTAL PRIMARY CONTAINER QUANTITY: 48
Related Searches:
P315
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505001490746
NSN
6505-00-149-0746
P315
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505001490746
NSN
6505-00-149-0746
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEXACHLOROPHENE CLEANSING EMULSION USP 5 FL OZ (148ML) 48S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 FLUID OUNCES OR 148.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SUBSTITUTE FOR PREFERRED NSN 6505-01-077-4952
TOTAL PRIMARY CONTAINER QUANTITY: 48
Related Searches:
PHISOHEX
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505001490746
NSN
6505-00-149-0746
PHISOHEX
HEXACHLOROPHENE CLEANSING EMULSION,USP
NSN, MFG P/N
6505001490746
NSN
6505-00-149-0746
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V HEXACHLOROPHENE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEXACHLOROPHENE CLEANSING EMULSION USP 5 FL OZ (148ML) 48S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 FLUID OUNCES OR 148.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SUBSTITUTE FOR PREFERRED NSN 6505-01-077-4952
TOTAL PRIMARY CONTAINER QUANTITY: 48
Related Searches:
NDC00998-0635-05
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505001491318
NSN
6505-00-149-1318
NDC00998-0635-05
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505001491318
NSN
6505-00-149-1318
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION USP 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
4469
ALLOPURINOL TABLETS,USP
NSN, MFG P/N
6505001491438
NSN
6505-00-149-1438
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS ALLOPURINOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00409-1590-05
WATER FOR INJECTION,STERILE,USP
NSN, MFG P/N
6505001491720
NSN
6505-00-149-1720
NDC00409-1590-05
WATER FOR INJECTION,STERILE,USP
NSN, MFG P/N
6505001491720
NSN
6505-00-149-1720
MFG
HOSPIRA INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: WATER FOR INJECTION STERILE USP 1000 ML 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00074-1587-50
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001493500
NSN
6505-00-149-3500
NDC00074-1587-50
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001493500
NSN
6505-00-149-3500
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE,W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION USP 0.25% 50ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL,MULTIPLE DOSE
Related Searches:
NDC00024-1214-02
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001493502
NSN
6505-00-149-3502
NDC00024-1214-02
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001493502
NSN
6505-00-149-3502
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.750 PERCENTAGE,W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION 0.75% 30ML AMPUL 5 AMPULS BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: SINGLE-DOSE VIAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00074-1582-30
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001493502
NSN
6505-00-149-3502
NDC00074-1582-30
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001493502
NSN
6505-00-149-3502
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.750 PERCENTAGE,W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION 0.75% 30ML AMPUL 5 AMPULS BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: SINGLE-DOSE VIAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 5